ID

22425

Description

Bortezomib and CHOP in Patients With Advanced Stage Aggressive T Cell or Natural Killer (NK)/T Cell Lymphomas; ODM derived from: https://clinicaltrials.gov/show/NCT00374699

Link

https://clinicaltrials.gov/show/NCT00374699

Keywords

Versions (1)
  1. 6/2/17 6/2/17 -
Uploaded on

June 2, 2017

DOI

To request one please log in.

License

Creative Commons BY 4.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Peripheral T-Cell Lymphomas NCT00374699

English

Eligibility Peripheral T-Cell Lymphomas NCT00374699

1 forms  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
histologically confirmed ptcls and nk/t cell lymphomas excluding anaplastic lymphoma kinase (alk)-positive anaplastic large cell t-cell lymphomas (alcl)
Description

Peripheral T-Cell Lymphoma | Lymphoma, Extranodal NK-T-Cell | Anaplastic large T-cell lymphoma Anaplastic lymphoma kinase Positive

Data type

boolean

Alias
UMLS CUI [1]
C0079774
UMLS CUI [2]
C1955906
UMLS CUI [3,1]
C1275317
UMLS CUI [3,2]
C0252409
UMLS CUI [3,3]
C1514241
performance status (ecog) ≤ 3
Description

ECOG performance status

Data type

boolean

Alias
UMLS CUI [1]
C1520224
age ≤ 65
Description

Age

Data type

boolean

Alias
UMLS CUI [1]
C0001779
at least one or more unidimensionally measurable lesion(s)
Description

Measurable Disease Linear Quantity

Data type

boolean

Alias
UMLS CUI [1,1]
C1513041
UMLS CUI [1,2]
C0205132
UMLS CUI [1,3]
C1265611
≥ 2 cm by conventional computed tomography (ct)
Description

Lesion size X-Ray Computed Tomography

Data type

boolean

Alias
UMLS CUI [1,1]
C0449453
UMLS CUI [1,2]
C0040405
≥ 1 cm by spiral ct
Description

Lesion size Spiral Computed Tomography

Data type

boolean

Alias
UMLS CUI [1,1]
C0449453
UMLS CUI [1,2]
C0860888
skin lesion (photographs should be taken)
Description

Skin lesion Photograph

Data type

boolean

Alias
UMLS CUI [1,1]
C0037284
UMLS CUI [1,2]
C0441468
measurable lesion by physical examination
Description

Measurable Disease Physical Examination

Data type

boolean

Alias
UMLS CUI [1,1]
C1513041
UMLS CUI [1,2]
C0031809
laboratory values
Description

Laboratory Results

Data type

boolean

Alias
UMLS CUI [1]
C1254595
creatinine (cr) < 1.5 mg% or creatinine clearance (ccr) > 50 ml/min
Description

Creatinine measurement, serum | Creatinine clearance measurement

Data type

boolean

Alias
UMLS CUI [1]
C0201976
UMLS CUI [2]
C0373595
transaminase < 3 x upper normal value
Description

Transaminases

Data type

boolean

Alias
UMLS CUI [1]
C0002594
bilirubin < 2.0 mg/dl
Description

Serum total bilirubin measurement

Data type

boolean

Alias
UMLS CUI [1]
C1278039
absolute neutrophil count (anc) > 1,500/ul
Description

Absolute neutrophil count

Data type

boolean

Alias
UMLS CUI [1]
C0948762
platelets > 75,000/ul
Description

Platelet Count measurement

Data type

boolean

Alias
UMLS CUI [1]
C0032181
informed consent
Description

Informed Consent

Data type

boolean

Alias
UMLS CUI [1]
C0021430
ann arbor stage iii or iv
Description

Ann Arbor lymphoma staging system

Data type

boolean

Alias
UMLS CUI [1]
C0432516
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
any other malignancies within the past 5 years except basal cell skin cancer or carcinoma in situ (cis) of the cervix
Description

Malignant Neoplasms | Basal cell carcinoma | Carcinoma in situ of uterine cervix

Data type

boolean

Alias
UMLS CUI [1]
C0006826
UMLS CUI [2]
C0007117
UMLS CUI [3]
C0851140
serious comorbid diseases
Description

Comorbidity Serious

Data type

boolean

Alias
UMLS CUI [1,1]
C0009488
UMLS CUI [1,2]
C0205404
pregnancy or breast feeding
Description

Pregnancy | Breast Feeding

Data type

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
any waiver of these inclusion and exclusion criteria must be approved by the investigator and the sponsor on a case-by-case basis prior to enrolling the subject. this must be documented by both the sponsor and the investigator. no subject will be allowed to enroll in this study more than once.
Description

Study Subject Participation Status

Data type

boolean

Alias
UMLS CUI [1]
C2348568
Back to the top of the page

Similar models

Eligibility Peripheral T-Cell Lymphomas NCT00374699

1 forms
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
Peripheral T-Cell Lymphoma | Lymphoma, Extranodal NK-T-Cell | Anaplastic large T-cell lymphoma Anaplastic lymphoma kinase Positive
Item
histologically confirmed ptcls and nk/t cell lymphomas excluding anaplastic lymphoma kinase (alk)-positive anaplastic large cell t-cell lymphomas (alcl)
boolean
C0079774 (UMLS CUI [1])
C1955906 (UMLS CUI [2])
C1275317 (UMLS CUI [3,1])
C0252409 (UMLS CUI [3,2])
C1514241 (UMLS CUI [3,3])
ECOG performance status
Item
performance status (ecog) ≤ 3
boolean
C1520224 (UMLS CUI [1])
Age
Item
age ≤ 65
boolean
C0001779 (UMLS CUI [1])
Measurable Disease Linear Quantity
Item
at least one or more unidimensionally measurable lesion(s)
boolean
C1513041 (UMLS CUI [1,1])
C0205132 (UMLS CUI [1,2])
C1265611 (UMLS CUI [1,3])
Lesion size X-Ray Computed Tomography
Item
≥ 2 cm by conventional computed tomography (ct)
boolean
C0449453 (UMLS CUI [1,1])
C0040405 (UMLS CUI [1,2])
Lesion size Spiral Computed Tomography
Item
≥ 1 cm by spiral ct
boolean
C0449453 (UMLS CUI [1,1])
C0860888 (UMLS CUI [1,2])
Skin lesion Photograph
Item
skin lesion (photographs should be taken)
boolean
C0037284 (UMLS CUI [1,1])
C0441468 (UMLS CUI [1,2])
Measurable Disease Physical Examination
Item
measurable lesion by physical examination
boolean
C1513041 (UMLS CUI [1,1])
C0031809 (UMLS CUI [1,2])
Laboratory Results
Item
laboratory values
boolean
C1254595 (UMLS CUI [1])
Creatinine measurement, serum | Creatinine clearance measurement
Item
creatinine (cr) < 1.5 mg% or creatinine clearance (ccr) > 50 ml/min
boolean
C0201976 (UMLS CUI [1])
C0373595 (UMLS CUI [2])
Transaminases
Item
transaminase < 3 x upper normal value
boolean
C0002594 (UMLS CUI [1])
Serum total bilirubin measurement
Item
bilirubin < 2.0 mg/dl
boolean
C1278039 (UMLS CUI [1])
Absolute neutrophil count
Item
absolute neutrophil count (anc) > 1,500/ul
boolean
C0948762 (UMLS CUI [1])
Platelet Count measurement
Item
platelets > 75,000/ul
boolean
C0032181 (UMLS CUI [1])
Informed Consent
Item
informed consent
boolean
C0021430 (UMLS CUI [1])
Ann Arbor lymphoma staging system
Item
ann arbor stage iii or iv
boolean
C0432516 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Malignant Neoplasms | Basal cell carcinoma | Carcinoma in situ of uterine cervix
Item
any other malignancies within the past 5 years except basal cell skin cancer or carcinoma in situ (cis) of the cervix
boolean
C0006826 (UMLS CUI [1])
C0007117 (UMLS CUI [2])
C0851140 (UMLS CUI [3])
Comorbidity Serious
Item
serious comorbid diseases
boolean
C0009488 (UMLS CUI [1,1])
C0205404 (UMLS CUI [1,2])
Pregnancy | Breast Feeding
Item
pregnancy or breast feeding
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Study Subject Participation Status
Item
any waiver of these inclusion and exclusion criteria must be approved by the investigator and the sponsor on a case-by-case basis prior to enrolling the subject. this must be documented by both the sponsor and the investigator. no subject will be allowed to enroll in this study more than once.
boolean
C2348568 (UMLS CUI [1])
Back to the top of the page 

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial